as on December 26, 2025 at 4:01 pm IST
Day's Low
Day's High
0.22%
Downside
2.20%
Upside
52 Week's Low
52 Week's High
1.53%
Downside
85.19%
Upside
as on December 26, 2025 at 4:01 pm IST
Market Cap
₹72.04 Cr
Return on Equity (ROE)
10.39
PE Ratio (TTM)
0Return on capital employed (ROCE)
13.6
Beta (LTM)
0.94
P/B Ratio
1.35
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-122.18
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Samrat Pharmachem with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 72.04 | 15.6% | 0.00 | 7 | 285 | |
| NA | 165.72 | 44.81% | 0.00 | 1 | 19 | |
| NA | 794.16 | 1.02% | 0.00 | 33 | 264 | |
| 2,499.48 | -10.6% | 0.72 | -567 | 1,283 | ||
| NA | 11.67 | -8.79% | 0.00 | -1 | 2 |
Get share price movements and forecasts by analysts on Samrat Pharmachem.
Source: S&P Global Market Intelligence
Search interest for Samrat Pharmachem Ltd Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Samrat Pharmachem.
Samrat Pharmachem Ltd’s net profit fell -122.18% since last year same period to ₹0.59Cr in the Q2 2025-2026. On a quarterly growth basis, Samrat Pharmachem Ltd has generated -156.52% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Samrat Pharmachem Ltd has declared dividend of ₹1.00 per share on 30 May 2025 - translating a dividend yield of 0.86%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 49.09% of holdings in Sep 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 47.67% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 144.3% return, outperforming this stock by 213.3%
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 12.1% return, outperforming this stock by 50.0%
Price Dip
![]()
In the last 3 years, Samrat Pharma stock has moved down by -69.0%
| Organisation | Samrat Pharmachem Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Lalit Mehta |
| E-voting on shares | Click here to vote |
Samrat Pharmachem share price today stands at ₹229.5 as on at the close of the market. Samrat Pharmachem share today touched a day high of ₹234.55 and a low of ₹229.
Samrat Pharmachem touched a 52 week high of ₹425 and a 52 week low of ₹226. Samrat Pharmachem share price today i.e. is closed at ₹229.5, which is -46.00% down from its 52 week high and 1.55% up from its 52 week low.
Samrat Pharmachem market capitalisation is ₹72.04 Cr as on .
To buy Samrat Pharmachem shares, you need to follow these steps:
Samrat Pharmachem trading volume is 1,888.00 as on . This means that 1,888.00 shares of Samrat Pharmachem were bought and sold on the stock market during today's trading session.